{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:03:09Z","timestamp":1779210189587,"version":"3.51.4"},"reference-count":82,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Oxidative stress is the result of an imbalance in the redox state in a cell or a tissue. When the production of free radicals, which are physiologically essential for signaling, exceeds the antioxidant capability, pathological outcomes including oxidative damage to macromolecules, aberrant signaling, and inflammation can occur. Down syndrome (DS) and Williams-Beuren syndrome (WBS) are well-known and common genetic conditions with multi-systemic involvement. Their etiology is linked to oxidative stress with important causative genes, such as SOD-1 and NCF-1, respectively, of the diseases being primarily involved in the regulation of the redox state. Early aging, dementia, autoimmunity, and chronic inflammation are some of the main characteristics of these conditions that can be associated with oxidative stress. In recent decades, there has been a growing interest in the possible role of oxidative stress and inflammation in the pathology of these conditions. However, at present, few studies have investigated these correlations. We provide an overview of the current literature concerning the role of oxidative stress and oxidative damage in genetic syndromes with a focus on Down syndrome and WBS. We hope to provide new insights to improve the management of complications related to these diseases.<\/jats:p>","DOI":"10.3390\/molecules26113139","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:35:05Z","timestamp":1621899305000},"page":"3139","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-4028","authenticated-orcid":false,"given":"Marta","family":"Ferrari","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Florence, Anna Meyer Children\u2019s University Hospital, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Stagi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, Anna Meyer Children\u2019s University Hospital, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/0002-9343(91)90279-7","article-title":"Reactive oxygen species in living systems: Source, biochemistry, and role in human disease","volume":"91","author":"Halliwell","year":"1991","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20140772","article-title":"Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: Overlaps in Down\u2019s syndrome and Alzheimer\u2019s disease brain","volume":"463","author":"Butterfield","year":"2014","journal-title":"Biochem. J."},{"key":"ref_5","first-page":"200","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"70","author":"Andreyev","year":"2005","journal-title":"Biochemistry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/383170","article-title":"Oxidative Stress and Mitochondrial Dysfunction in Down\u2019s Syndrome: Relevance to Aging and Dementia","volume":"2012","author":"Coskun","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2017.07.009","article-title":"Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism","volume":"114","author":"Barone","year":"2018","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/HYPERTENSIONAHA.113.02087","article-title":"Williams Syndrome Predisposes to Vascular Stiffness Modified by Antihypertensive Use and Copy Number Changes inNCF1","volume":"63","author":"Kozel","year":"2014","journal-title":"Hypertension"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Damiano, S., Sozio, C., La Rosa, G., Guida, B., Faraonio, R., Santillo, M., and Mondola, P. (2020). Metabolism Regulation and Redox State: Insight into the Role of Superoxide Dismutase 1. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186606"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10522-010-9269-4","article-title":"Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome","volume":"11","author":"Lloret","year":"2010","journal-title":"Biogerontology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/541230","article-title":"Oxidative Stress and Mitochondrial Dysfunction across Broad-Ranging Pathologies: Toward Mitochondria-Targeted Clinical Strategies","volume":"2014","author":"Pagano","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in Down syndrome: Unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Muchov\u00e1, J., \u017dit\u0148anov\u00e1, I., and \u010eura\u010dkov\u00e1, Z. (2014). Oxidative Stress and Down Syndrome. Do Antioxidants Play a Role in Therapy?. Physiol. Res., 535\u2013542.","DOI":"10.33549\/physiolres.932722"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-3806(84)90060-9","article-title":"Superoxide Dismutase, Glutathione Peroxidase and Lipoperoxidation in Down\u2019s Syndrome Fetal Brain","volume":"16","author":"Brooksbank","year":"1984","journal-title":"Dev. Brain Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1073\/pnas.84.22.8044","article-title":"Transgenic mice with increased Cu\/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome","volume":"84","author":"Epstein","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","article-title":"Multiple evidence for an early age pro-oxidant state in Down Syndrome patients","volume":"7","author":"Degan","year":"2006","journal-title":"Biogerontology"},{"key":"ref_19","first-page":"1","article-title":"Genetic dissection of down syndrome-associated alterations in APP\/amyloid-\u03b2 biology using mouse models","volume":"11","author":"Tosh","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/724904","article-title":"Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia","volume":"2012","author":"Perluigi","year":"2011","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_21","first-page":"776","article-title":"Apoptosis and increased generation of reactive oxygen species in Down\u2019s Syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nat. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/bies.10138","article-title":"Mitochondrial dysfunction and Down\u2019s syndrome","volume":"24","author":"Arbuzova","year":"2002","journal-title":"BioEssays"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in Down Syndrome: Molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive Downregulation of Mitochondrial Function in Down Syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.1985.tb21489.x","article-title":"Molecular Structure and Expression of the Gene Locus on Chromosome 21 Encoding the Cu\/Zn Superoxide Dismutase and Its Relevance to Down Syndrome","volume":"450","author":"Groner","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0197-4580(95)00066-N","article-title":"Are reactive oxygen species involved in Alzheimer\u2019s disease?","volume":"16","author":"Benzi","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neurobiolaging.2006.03.008","article-title":"Oxidative stress: A bridge between Down\u2019s syndrome and Alzheimer\u2019s disease","volume":"28","author":"Zana","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.freeradbiomed.2004.05.019","article-title":"Aberrant Neuronal and Mitochondrial Proteins in Hippocampus of Transgenic Mice Overexpressing Human Cu\/Zn Superoxide Dismutase 1","volume":"37","author":"Shin","year":"2004","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid \u03b2 precursor protein is associated with mitochondrial dysfunction in Down\u2019s syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lubec, G. (2001). Antioxidant proteins in fetal brain: Superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. Protein Expression in Down Syndrome Brain, Springer.","DOI":"10.1007\/978-3-7091-6262-0"},{"key":"ref_32","first-page":"36","article-title":"Exploring SOD1 Gene for the Detection of Fetal Down Syndrome","volume":"2","author":"Karuppiah","year":"2008","journal-title":"J. Prenat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/01443615.2016.1250730","article-title":"Screening of potential biomarkers for prenatal diagnosis of trisomy 21","volume":"37","author":"Ma","year":"2016","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.it.2018.01.005","article-title":"Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism","volume":"39","author":"Franchina","year":"2018","journal-title":"Trends Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.3810169","article-title":"Characterization and Chromosomal Localimtion of a cDNA Encoding Brain Amyloid of Alzheimer\u2019s Disease","volume":"235","author":"Goldgaber","year":"1987","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/febs.14004","article-title":"The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the \u201camyloid cascade hypothesis\u201d","volume":"284","author":"Hardy","year":"2017","journal-title":"FEBS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2016.10.508","article-title":"HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology","volume":"111","author":"Barone","year":"2017","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: Mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2013","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.stemcr.2018.05.004","article-title":"The Impact of APP on Alzheimer-like Pathogenesis and Gene Expression in Down Syndrome iPSC-Derived Neurons","volume":"11","author":"Ovchinnikov","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.18632\/aging.102677","article-title":"Down syndrome and Alzheimer\u2019s disease: Common molecular traits beyond the amyloid precursor protein","volume":"12","author":"Gomez","year":"2020","journal-title":"Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2017.09.013","article-title":"Down syndrome, beta-amyloid and neuroimaging","volume":"114","author":"Head","year":"2018","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1089\/ars.2011.4109","article-title":"Redox proteomics in selected neurodegenerative disorders: From its infancy to future applications","volume":"17","author":"Butterfield","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Boil."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","article-title":"Intracellular and extracellular roles of S100 proteins","volume":"60","author":"Donato","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B\u2019s double life: Intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta BBA Bioenerg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/hmg\/ddm322","article-title":"Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury","volume":"17","author":"Esposito","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2990.1999.00196.x","article-title":"Overexpression of S100b in Down\u2019s syndrome: Correlation with patient age and with b-amyloid deposition","volume":"25","author":"Royston","year":"1999","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/156720506779025305","article-title":"Beta-amyloid, oxidative stress and down syndrome","volume":"3","author":"Lott","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.5107-04.2005","article-title":"ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down\u2019s Syndrome Neurons","volume":"25","author":"Helguera","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.2001.5680","article-title":"Ets-2 Is Induced by Oxidative Stress and Sensitizes Cells to H2O2-Induced Apoptosis: Implications for Down\u2019s Syndrome","volume":"287","author":"Sanij","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4296985","article-title":"Bach1: Function, Regulation, and Involvement in Disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1\/BVR-A System: Insights for Transition to Alzheimer\u2019s Disease","volume":"44","author":"Pupo","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-\u03b2CTF (C99)","volume":"39","author":"Jiang","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Perluigi, M., Tramutola, A., Pagnotta, S., Barone, E., and Butterfield, D.A. (2020). The BACH1\/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia. Antioxidants, 9.","DOI":"10.3390\/antiox9090779"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajmg.a.38156","article-title":"The proceedings of the 15th professional conference on Williams Syndrome","volume":"173","author":"Walton","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.ridd.2014.07.056","article-title":"Aging and sleep in Williams syndrome: Accelerated sleep deterioration and decelerated slow wave sleep decrement","volume":"35","author":"Gombos","year":"2014","journal-title":"Res. Dev. Disabil."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMra0903074","article-title":"Williams\u2013Beuren Syndrome","volume":"362","author":"Pober","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican1297-68","article-title":"Williams Syndrome and the Brain","volume":"277","author":"Lenhoff","year":"1997","journal-title":"Sci. Am."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajmg.a.33300","article-title":"Pulmonary function and emphysema in Williams-Beuren syndrome","volume":"152","author":"Wan","year":"2010","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajmg.a.30970","article-title":"Sensorineural hearing loss in children and adults with Williams syndrome","volume":"138","author":"Marler","year":"2005","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3476(88)80272-5","article-title":"Natural history of Williams syndrome: Physical characteristics","volume":"113","author":"Morris","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1207\/s15326942dn2603_3","article-title":"Age-Associated Memory Changes in Adults with Williams Syndrome","volume":"26","author":"Devenny","year":"2004","journal-title":"Dev. Neuropsychol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1096-8628(19990423)83:5<356::AID-AJMG2>3.0.CO;2-X","article-title":"Elevated ambulatory blood pressure in 20 subjects with Williams syndrome","volume":"83","author":"Broder","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.a.30012","article-title":"Risk of sudden death in the Williams-Beuren syndrome","volume":"127","author":"Wessel","year":"2004","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI19028","article-title":"Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency","volume":"112","author":"Faury","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"44926","DOI":"10.1074\/jbc.M111.274779","article-title":"Genetic Modifiers of Cardiovascular Phenotype Caused by Elastin Haploinsufficiency Act by Extrinsic Noncomplementation*","volume":"286","author":"Kozel","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/ATVBAHA.108.181610","article-title":"NADPH Oxidases: Functions and Pathologies in the Vasculature","volume":"30","author":"Griendling","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.freeradbiomed.2011.06.011","article-title":"Oxidases and peroxidases in cardiovascular and lung disease: New concepts in reactive oxygen species signaling","volume":"51","author":"Khoo","year":"2011","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/501073","article-title":"Hemizygosity at the NCF1 Gene in Patients with Williams-Beuren Syndrome Decreases Their Risk of Hypertension","volume":"78","author":"Antonell","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure: Role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Campuzano, V., Segura-Puimedon, M., Terrado, V., S\u00e1nchez-Rodr\u00edguez, C., Coustets, M., Menacho-M\u00e1rquez, M., Nevado, J., Bustelo, X.R., Francke, U., and P\u00e9rez-Jurado, L.A. (2012). Reduction of NADPH-Oxidase Activity Ameliorates the Cardiovascular Phenotype in a Mouse Model of Williams-Beuren Syndrome. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002458"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1093\/hmg\/ddu368","article-title":"Heterozygous deletion of the Williams\u2013Beuren syndrome critical interval in mice recapitulates most features of the human disorder","volume":"23","author":"Velot","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"L778","DOI":"10.1152\/ajplung.00352.2006","article-title":"Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysema","volume":"292","author":"Shifren","year":"2007","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2018.09.014","article-title":"The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development","volume":"175","author":"Tebbenkamp","year":"2018","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Egea, G., Jim\u00e9nez-Altay\u00f3, F., and Campuzano, V. (2020). Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue. Antioxidants, 9.","DOI":"10.3390\/antiox9101013"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4614-0653-2_22","article-title":"Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome","volume":"Volume 724","author":"Pagano","year":"2012","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jped.2016.04.012","article-title":"Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: Clinical and biochemical aspects","volume":"93","author":"Zaki","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pediatrneurol.2007.08.003","article-title":"Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children with Trisomy 21","volume":"37","author":"Miles","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/biof.184","article-title":"Mitochondrial dysfunction and Down\u2019s syndrome: Is there a role for coenzyme Q10?","volume":"37","author":"Tiano","year":"2011","journal-title":"BioFactors"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/alz.12185","article-title":"Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model","volume":"17","author":"Chen","year":"2021","journal-title":"Alzheimers Dement."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/11\/3139\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:58Z","timestamp":1760162818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/11\/3139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":82,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["molecules26113139"],"URL":"https:\/\/doi.org\/10.3390\/molecules26113139","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}